| |
| |
| Foreword | |
| |
| |
| A Brief History of Ideas About Platelets in Health and Disease | |
| |
| |
| |
| |
| Platelet Biology | |
| |
| |
| |
| The Evolution of Mammalian Platelets | |
| |
| |
| |
| |
| Megakaryocyte Development and Platelet Formation | |
| |
| |
| |
| |
| The regulation of platelet life span | |
| |
| |
| |
| |
| Platelet Genomics | |
| |
| |
| |
| |
| Platelet MicroRNAs | |
| |
| |
| |
| |
| The Platelet Proteome | |
| |
| |
| |
| |
| Platelet Structure | |
| |
| |
| |
| |
| The Platelet Cytoskeleton | |
| |
| |
| |
| |
| Platelet Receptors | |
| |
| |
| |
| |
| The GPIb-IX-V Complex | |
| |
| |
| |
| |
| GPVI and CLEC-2 | |
| |
| |
| |
| |
| Integrin AlphaIIb Beta3 | |
| |
| |
| |
| |
| Protease-activated Receptors | |
| |
| |
| |
| |
| The Platelet P2 Receptors | |
| |
| |
| |
| |
| PECAM-1 | |
| |
| |
| |
| |
| Interactions Between Platelets, Leukocytes and the Endothelium | |
| |
| |
| |
| |
| Inhibition of Platelet Function by the Endothelium | |
| |
| |
| |
| |
| Platelet Secretion | |
| |
| |
| |
| |
| Signal Transduction During Platelet Plug Formation | |
| |
| |
| |
| |
| Platelet Thrombus Formation in Flowing Blood | |
| |
| |
| |
| |
| Interactions Between Platelets and the Coagulation System | |
| |
| |
| |
| |
| Platelet-Derived MicroParticles | |
| |
| |
| |
| |
| The Role of Platelets in Fibrinolysis | |
| |
| |
| |
| |
| The Role of Platelets in Angiogenesis | |
| |
| |
| |
| |
| Platelet Function in the Newborn | |
| |
| |
| |
| |
| Tests of Platelet Function | |
| |
| |
| |
| Clinical Tests of Platelet Function | |
| |
| |
| |
| |
| Platelet Counting | |
| |
| |
| |
| |
| Platelet Aggregation | |
| |
| |
| |
| |
| Flow Cytometry | |
| |
| |
| |
| |
| Monitoring of Antiplatelet Therapy | |
| |
| |
| |
| |
| Real Time In Vivo Imaging of Platelets During Thrombus Formation | |
| |
| |
| |
| |
| The Role of Platelets in Disease | |
| |
| |
| |
| Atherothrombosis and Coronary Artery Disease | |
| |
| |
| |
| |
| Central Nervous System Ischemia | |
| |
| |
| |
| |
| Peripheral Vascular Disease | |
| |
| |
| |
| |
| Diabetes Mellitus | |
| |
| |
| |
| |
| Inflammation | |
| |
| |
| |
| |
| Antimicrobial Host Defense | |
| |
| |
| |
| |
| Tumor Growth and Metastasis | |
| |
| |
| |
| |
| Disorders of Platelet Number and Function | |
| |
| |
| |
| The Clinical Approach to Disorders of Platelet Number and Function | |
| |
| |
| |
| |
| Immune Thrombocytopenia (ITP) | |
| |
| |
| |
| |
| Drug-induced Thrombocytopenia | |
| |
| |
| |
| |
| Heparin-induced Thrombocytopenia | |
| |
| |
| |
| |
| Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndrome | |
| |
| |
| |
| |
| Thrombocytopenia in Pregnancy | |
| |
| |
| |
| |
| Thrombocytopenia in the Newborn | |
| |
| |
| |
| |
| Alloimmune Thrombocytopenia | |
| |
| |
| |
| |
| Inherited Thrombocytopenias | |
| |
| |
| |
| |
| Pseudothrombocytopenia | |
| |
| |
| |
| |
| Thrombocytosis and Essential Thrombocythemia | |
| |
| |
| |
| |
| Congenital Disorders of Platelet Function | |
| |
| |
| |
| |
| Acquired Disorders of Platelet Function | |
| |
| |
| |
| |
| Cardiopulmonary Bypass | |
| |
| |
| |
| |
| Antiplatelet Therapy | |
| |
| |
| |
| Aspirin | |
| |
| |
| |
| |
| ADP Receptor Antagonists | |
| |
| |
| |
| |
| AlphaIIb Beta3 (GPIIb-IIIa) Antagonists | |
| |
| |
| |
| |
| Dipyridamole | |
| |
| |
| |
| |
| Cilostazol | |
| |
| |
| |
| |
| Novel Antiplatelet Therapies | |
| |
| |
| |
| |
| Therapy to Increase Platelet Numbers and/or Function | |
| |
| |
| |
| Thrombopoietin Mimetics | |
| |
| |
| |
| |
| Desmopressin | |
| |
| |
| |
| |
| Factor VIIa | |
| |
| |
| |
| |
| Platelet Transfusion Medicine | |
| |
| |
| |
| |
| Making Platelets Ex Vivo | |
| |
| |
| |
| |
| Gene Therapy for Platelet Disorders | |
| |